Chapitre 14 - Bibliographie
Adachi K., Zhao Y., Surrey S.
Assembly of human hemoglobin (Hb) β- and γ-globin chains expressed in a cell-free system with α-globin chains to form Hb A and Hb F.
J. Biol. Chem., 277: 13415-13420, 2002.
Adedeji M.O., Ukoli F.A.M.
Haematological factors associated with the leg ulcers in sickle cell disease.
Trop. Geog. Med., 39: 354-356, 1987.
Adeloye A.
Sickle-cell anaemia.
Br. Med. J., 2: 304, 1973.
Adeloye A.
Some early Nigerian doctors and their contribution to modern medicine in West Africa.
Med. Hist., 18: 275-293, 1974.
Ajulo S.O., Osiname A.I., Myatt H.M.
Sensorineural hearing loss in sickle cell anaemia. A United Kingdon study.
J. Laryngol. Otol., 107, 790-794, 1993.
Alaqui F.Z.
Ostéonécroses aseptiques: aspects radio-cliniques.
Rev. Maroc Chir. Orthop. Traumato., 30: 5-11, 2007.
Alavi A., Bond J.P., Kuhl D.E., Creech R.H.
Scan detection of bone marrow infarcts in sickle cell disorders.
J. Nucl. Med., 15: 1003-1007, 1974.
Alexandre L., Kéclard L., Romana M.
Efficiency of prenatal counseling for sickle cell disease in Guadeloupe.
Genet. Couns., 8: 25-32, 1997.
Allen D.W., Wyman J.
Equilibre de l'hémoglobine de drépanocytose avec l'oxygène.
Rev. Hématol., 9: 155-157, 1954.
Allen D.W., Limbrich A.R., Thomas P.
Microvesicles from sickle erythrocytes and their relation to irreversible sickling.
Br. J. Haemat., 47: 383-390, 1981.
Allison A.C.
Protection afforded by sickle-cell trait against subtertian malaria infection.
Br. Med. J., 1: 290-294, 1954.
Allison A.C.
Two lessons from the interface of genetics and medicine.
Genetics, 166: 1591-1599, 2004.
Almklov J.R., Hansen A.E., Schneider M.
Long bone involvement in sickle cell anemia.
Pediatrics, 5: 204-209, 1950.
Al-Mousawi F.R., Malki A.A., Al-Aradi A.
Total hip replacement in sickle cell disease.
Int. Orthop., 26: 157-161, 2002.
Al-Mousawi F.R., Malki A.A.
Managing femoral head osteonecrosis in patients with sickle cell disease.
The Surgeon, 5: 282-289, 2007.
Andersch M.A., Wilson D.A., Menten M.S.
Sedimentation constants and electrophoretic mobilities of adult and fetal carbonylhemoglobin.
J. Biol. Chem., 163: 301-305, 1944.
Andrianne Y., Lamoureux J., Quintin J., Clémens M.
La hanche drépanocytaire et son traitement chirurgical.
Rev. Chir. Orthop., 69: 61-68, 1983.
Andrianne Y.
Communication personnelle, 2010.
Anetzberger H., Thein E., Becker M., Zwissler B., Messmer K.
Microspheres accurately predict regional bone blood flow.
Clin. Orthop., 424: 253-265, 2004.
Anionwu E.N., Walford D., Brozovi M., Kirkwood B.
Sickle-cell disease in a British urban community.
Br. Med. J., 282: 283-286, 1981.
Anionwu E.N., Patel N., Kanji G., Renges H., Brozović M.
Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.
J. Med. Genet., 25: 769-772, 1988.
ARCO
Association Research Circulation Osseous (ARCO): Committee on terminology and classification.
ARCO news, 4: 41-46, 1992.
Arlet J., Ficat P.
Forage-biopsie de la tête fémorale dans l’ostéonécrose primitive; observations histopathologiques portant sur huit cas.
Rev. Rhum. Mal. osteoartic., 31: 257-264, 1964.
Arlet J., Ficat P., Lartigue G.
Mode de début de l’ostéonécrose fémoro-capitale primitive. Etude de 20 observations histologiquement prouvées par le forage-biopsie (stade I non compliqué).
Rev. Rhum. Mal. osteoartic., 35: 239-249, 1968a.
Arlet J., Ficat P., Sebbag D.
Intérêt de la mesure de la pression intramédullaire dans le massif trochantérien chez l’homme en particulier pour le diagnostic de l’ostéonécrose fémoro-capitale.
Rev. Rhum. Mal. osteoartic., 35: 250-256, 1968b.
Arlet J., Ficat P., Lartigue G., Tran M.A.
Recherches cliniques sur la pression intra-osseuse dans la métaphyse et l’épiphyse fémorales supérieures chez l’homme.
Rev. Rhum., 39: 717-723, 1972.
Arlet J., Durroux R.
Diagnostic histologique précoce de l'ostéonécrose aseptique de la tête fémorale par le forage-biopsie.
In: "La circulation osseuse, compte rendu du 1er Symposium International sur la circulation osseuse".
INSERM Ed., Paris, 293-302, 1973.
Arlet J., Durroux R., Fauchier C., Thiechart M.
Histopathology of nontraumatic necrosis of the femoral head: topographic and evolutive aspects.
In: "Bone Circulation", J. Arlet, R.P. Ficat, D.S. Hungerford, Eds., Williams & Wilkins Pub., Baltimore, 296-305, 1984.
Arlet J.
Communication personnelle, Pointe à Pitre, 1995.
Arnoldi C.C., Linderholm H., Müssbichler H.
Venous engorgement and intraosseous hypertension in osteoarthritis of the hip.
J. Bone Joint Surg., 54B: 409-421, 1972.
Ataga K.I., Orringer E.P.
Renal abnormalities in sickle cell disease.
Am. J. Hematol., 63: 205-211, 2000.
Audouin J., Delacrétaz F., Diebold J., Dumont J., Le Tourneau A., Meugé-Moraw C.
Biopsie médullaire osseuse en pratique quotidienne.
Le Pathologiste, Collection dirigée par J. Diebold, Elsevier, Paris, pp. 352, 2004.
Azuma H.
Intraosseous pressure as a measure of hemodynamic changes in bone marrow.
Angiology, 15: 396-406, 1964.
Bachir D., Bonnet Gadjos M., Galacteros F.
La transfusion dans la drépanocytose.
Presse Méd., 19: 1627-1631, 1990.
Bachir D., Virag R., Lee K., Belloy M.
Prévention et traitement des troubles érectiles de la drépanocytose.
Rev. Med. interne, 18: 46-51, 1997.
Bain B.J.
Sickle cell hemoglobin and its interactions with other variants haemoglobins and with thalassaemias.
In: "Hemoglobinopathy diagnosis", B.J. Bain, Ed., Blackwell Pub., London, 139-188, 2001.
Baker J.R.
The cell-theory: a restatement, history, and critique. Part I Quart. J. Microscop. Science, 89: 103-125, 1948.
Ballas S.K.
Treatment of pain in adults with sickle cell disease.
Am. J. Hematol., 34: 49-54, 1990.
Balogun R.A., Obalum D.C., Giwa S.O., Adekoya-Cole T.O., Ogo C.N., Enweluzo G.O.
Spectrum of musculo-skeletal disorders in sickle cell disease in Lagos, Nigeria Orthop. Traumatol. Surg. Res., 5: 1-6, 2010.
Bardakdjian-Michau J., Dhondt J.L., Ducrocq R., Galactéros F., Guyard A., Huchet F.X., Lahary A., Lena-Russo D., Maboudou P., North M.L., Prehu C., Soummer A.M., Verschelde M., Wajcman H.
Bonnes pratiques de l’étude de l’hémoglobine.
Groupe de travail SFBC "Recommandations dans le domaine des diagnostics des hémoglobinopathies".
Ann. Biol. Clin., 61: 401-409, 2003.
Bardakdjian-Michau J., Wajcman H.
Épidémiologie de la drépanocytose.
Rev. Prat., 54: 1531-1533, 2004.
Bardakdjian-Michau J., Bahuau M., Hurtrel D., Godart C., Riou J., Mathis M., Goossens M.
Neonatal screening for sickle cell disease in France.
J. Clin. Path., 62: 31-33, 2009.
Baroldi G.
High resistance of the human myocardium to shock and red blood cell aggregation (Sludge).
Cardiologia, 54: 271-277, 1969.
Barrère J., Wajcman H.
La drépanocytose.
Mise à jour : 23/10/2001.
http://www.inrp.fr/Acces/biotic/gpe/dossiers/drepanocytose/html/synthese.htm (consulté le 21.12.2007)
Barrère J., Hervé J.C., Dupuis M.
Répartition géographique de l’allèle du gène S.
http://www.inrp.fr/Acces/biotic/evolut/mecanismes/globines/html/demarche.htm (dernière mise à jour, 13/3/2005)
Barret-Connor E.
Bacterial infection and sickle-cell anemia: an analysis of 250 infections in 166 patients and a review of the literature.
Medecine, 50: 97-112, 1971.
Barrett-Connor E.
Pneumonia and pulmonary infarction in sickle cell anemia.
JAMA, 224: 997-1000, 1973.
Barrett D.H., Wisotzek I.E., Abel G.G., Pouleau J.L., Platt A.F., Pollard W.E., Eckman J.R.
Assessment of psychosocial functionning of patients with sickle cell disease.
South. Med. J., 81: 735-750, 1988.
Baskurt O.K.
Pathophysiological significance of blood rheology.
Turk. J. Med. Sci., 33: 347-355, 2003.
Batisse R., Ducloux J-M., Debongière C.
Aspects radiologiques des manifestations osseuses de la drépanocytose.
Ann. Méd. interne, 122: 405-412, 1971.
Baum K.F., Dunn D.T., Maude G.H., Serjeant G.R.S.
The painfull crisis of homozygous sickle cell disease. A study of risk factors.
Arch. Intern. Med., 147: 1231-1234, 1987.
Beauvais P.
Les accidents vasculaires cérébraux de la drépanocytose.
Sang Thrombose Vaisseaux, Vol. 8: 505-510, 1996.
Bégué P., Castello-Herbretau B.
La drépanocytose: de l’enfant à l’adolescent. Prise en charge.
Bull. Soc. Pathol. Exot., 94: 85-89, 2001.
Behe M.J., Englander S.W.
Sickle hemoglobin gelation. Reaction order and critical nucleus size.
Biophys. J., 23: 129-145, 1978.
Belcher J.M., Marker P.M., Weber J.P.
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.
Blood, 96: 2451-54, 2000.
Bellot F., Havet E., Gabrion A., Meunier W., Mertl P., de Lestang M.
Résultats des forages pour ostéonécrose aseptique de la tête fémorale.
Rev. Chir. Orthop., 91: 114-123, 2005.
Beltran J., Herman L.J., Burk J.M., Zuelzer T., Clark R.N., Lucas J.G., Weiss L.D., Yang A.
Femoral head avascular necrosis: MR imaging with clinical pathologic and radionuclide correlation.
Radiology, 166: 215-220, 1988.
Benesch R.E., Edalji R., Benesch R.
Reciprocal interaction of hemoglobin with oxygen and protons. The influence of allosteric polyanions.
Biochemistry, 16: 2594-2597, 1977.
Benkerrou M.
Le dépistage néonatal ciblé de la drépanocytose en France métropolitaine: raisons et résultats.
Med. Ther. Pédiatrie, 5: 159-163, 2002.
Benton T.D., Ifeagwu J.A., Smith-Whitley K.
Anxiety and depression in children and adolescents with sickle cell disease.
Current Psychiatry Reports, 9: 114-121, 2007.
Berchel C., Diara J.P., Loret H., Foucan L., Le Turdu C., Samuel Y.
Histoire naturelle de la drépanocytose.
Rev. Prat., 42: 1885-1891, 1992.
Berkane N., Nizard J., Dreux B., Uzan S., Girot R.
Drépanocytose et grossesse. Complication et prise en charge.
Path. Biol., 47: 46-54, 1999.
Bernard Cl.
Edition électronique réalisée à partir du livre de Claude Bernard, Principes de médecine expérimentale (ou de d'expérimentation appliquée à la physiologie, à la pathologie et à la thérapeutique (fragments entre 1858 et 1877).
Paris: Les Presses universitaires de France, pp. 308, 1947.
Bernaudin F., Souillet G., Vannier J.P.
Bon marrow transplantation in 14 children with severe sickle cell disease: the french experience.
Bone Marrow Transpl., 12: 118-121, 1993.
Bernaudin F.
Résultats et indications de l’allogreffe de moelle dans la drépanocytose.
Pathol. Biol., 47: 59-64, 1999.
Bernstein S.C., Bowman J.E., Kaptue Noche L.
Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria.
Hum. Hered., 30: 251-258, 1980.
Bertles J.F., Milner P.F.A.
Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.
J. Clin. Invest., 47: 1731-1741, 1968.
Bertrand. E.
L’hémoglobinopathie AS est-elle sans risques?
Med. Trop., 65: 379-381, 2005.
Bessis M., Nomarski G., Thiery J.P., Breton-Gorius J.
Etude sur la falciformation des globules rouges au microscope polarisant et au microscope électronique.
II. L'intérieur du globule; comparaison avec les cristaux intra-globulaires.
Rev. Hematol., 13: 249-270, 1958.
Beuzard Y.
Thérapie génique et drépanocytose.
Réseau de la drépanocytose.
Communication personnelle, Hôpital Tenon, 08-10-2009.
Bibrac A., Etienne-Julan M.
Centre Caribéen Guy Mérault. Un modèle de prise en charge globale et intégrée.
In: "La drépanocytose: regards croisés sur une maladie orpheline", A. Lainé Ed., Karthala Pub., Paris, 199-211, 2004.
Billy-Brissac R., Blanchet-Deverly A., Etienne-Julan M., Foucan L.
Pulmonary hypertension in an adult sickle cell population in Guadeloupe.
Int. J. Cardiol., 135:122-123, 2009.
Binet J.L.
Le sang et les hommes.
Gallimard, Paris, pp. 127, 1988.
Bishop A.R., Roberson J.R., Eckman J.R., Fleming L.L.
Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.
J. Bone Joint Surg., 70A: 853-855, 1988.
Blum A., Yeganeh S. Peleg A.,Vigder F., Kryuger K., Khatib A., Khazim K., Dauerman H.
Endothelium function in patients with sickle cell anemia during and after sickle cell crisis.
J. Thromb. Thrombolysis, 19: 83-86, 2005.
Boehm C.D., Antonarakis S.E., Phillips J.A., Stetten G., Kazazian H.H.
Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia.
N. Engl. J. Med., 308: 1054-1058, 1983.
Bohr Ch., Hasselbalch K., Krogh A.
Über einen in biologischer Beziehung wichtigen Einfluss, den die Kohlensäurespannung des Blutes auf dessen Sauerstoffbindung übt.
Skand. Arch. Physiol., 16: 401-412, 1904.
Trans. by Marquardt U., 1997. http://www.udel.edu/chem/white/C342/Bohr(1904).html (Consulté le 06.09.2009).
Bohrer S.P.
Acute long bone diaphyseal infarcts in sickle cell disease.
Br. J. Radiol., 43: 685-697, 1970.
Bohrer S.P.
Fracture complication bone infarction and/or osteomyelitis in sickle-cell disease.
Clin. Radiol., 22: 83-88, 1971.
Boisseau M.R., Freyburger G., Roudaut M.F.,Yoyo S., Bertrand J.F.
Troubles homéorhéologiques au cours de la drépanocytose.
Méd. Afr. Noire, 32: 271-278, 1985.
Bouaré
Les résultats d’une enquête sur la gestion la qualité de la crise drépanocytaire par les agents de la santé Thèse, N°19, Université de Bamako, pp. 62, 2004.
http://www.keneya.net/fmpos/theses/2004/med/04M82/pdf/04M82.pdf (consulté le 07.02.10)
Brain P.
Sickle-cell anaemia in Africa.
Brit. Med. J., Oct. 18: 880, 1952.
Briehl R.W., Guzman A.E.
Fragility and structure of hemoglobin S fibers and gels and their consequences for gelation kinetics and rheology.
Blood, 83: 573-579, 1994.
Brittain F.E, Mlinar K.J., Anderson C.S., Orringer E.P., Parise L.V.
Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction.
J. Clin. Invest., 107: 1555-1562, 2001.
Bursaux E., Poyart C.
Altérations structurales et fonctionnelles de la membrane érythrocytaire dans la drépanocytose.
Bull. Eur. Physiopathol. Respir., 19: 345-350, 1983.
Bush V.
Science the endless frontier.
A Report to the President by Vannevar Bush, Director of the Office of Scientific Research and Development.
July 1945.
Cabannes R., Sangare A.
La thérapeutique de la crise drépanocytaire de l'enfant.
Méd. Afr. Noire, 23: 225-236, 1976.
Cabannes R., Sangare A., Garnier E., Kiple-Faget P., Abissey S.
Physiopathologie de la drépanocytose.
Méd. Afr. Noire, 26: 277-284, 1981.
Cackovic M., Chung C., Bolton L.L., Kerstein M.D.
Leg ulceration in sickle cell patient.
J. Am. Coll. Surg., 187: 307-309, 1998.
Calkins M.D., Fitzgerald G., Bentley T.B., Burris D.
Intraosseous infusion devices: a comparison for potential use in special operations.
J. Trauma, 48: 1068-1074, 2000.
Cappadoro M., Giribaldi G., O'Brien E., Turrini F., Mannu F., Ulliers D., Simula G., Luzzatto L., Arese P.
Early phagocytosis of Glucose-6-Phosphate Dehydrogenase (G6PD) deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
Blood, 92: 2527-2534, 1998.
Carayon A., Gruet M., Piquard B.
Gravité comparée des ostéomyélites chez les drépanocytaires et chez les sujets exempts de tare.
Bull. Soc. Méd. Afr. Noire, 15: 385-391, 1969.
Carayon A., Doury P., Pattin S., Zimmer C.
Les manifestations ostéo-articulaires des drépanocytoses.
Ann. Med. interne, 122: 419-426, 1971.
Carter R., Mendis K.N.
Evolutionary and historical aspects of the burden of malaria.
Clin. Microbiol. Rev., 15: 564-594, 2002.
Catonné Y.
Traitement des nécroses épiphysaires drépanocytaires.
Nouv. Rev. Fr. Hématol., 28: 209-210, 1986.
Catonné Y.
Aspects orthopédiques de la drépanocytose.
Cahiers Conférence d’Enseignement de la SOFCOT.
Elsevier, Paris, 79: 245-262, 2002.
Catonné Y., Mukisi Mukasa M., Rouvillain J.L., Ribeyre D.
Manifestations ostéo-articulaires de la drépanocytose.
Maîtrise Orthopédique, 135: 24-28, 2004.
Chang Y.C., Maier-Redelsperger M., Smith K.D., Contu L., Dubrocq R., De Montalembert M., Belloy M., Elion J., Dover G.J., Girot R.
The relative importance of the X-linked FCP locus an Bêta-globine haplotypes in determining heamoglobin F levels:
study of SS patients homozygous for Bêta S haplotype.
Br. Haematol., 96: 806-814, 1997.
Charache S., Terrin M.L., Moore R.D.
Effet of hydroxyurea of the frequency on painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia.
N. Engl. J. Med., 332: 1317-1322, 1995.
Cheng N., Burssens A., Mulier J.C.
Pregnancy and post-pregnancy avascular necrosis of the femoral head.
Arch. Orthop. Traumat. Surg., 100: 199-210, 1982.
Chien S.
Rheology of sickle cells and erythrocyte content.
Blood Cells, 3: 283-303, 1977.
Chippaux C., Bourrel P.
Lésions osseuses et drépanocytose en pays africains.
Bull. Mém. Soc. Anthrop. Paris., tome 3, série XIII, 337-344, 1976.
Chung C., Cackovic M., Kesrstein M.D.
Leg ulcers in patient with sickle cell disease.
Adv. Wound Care, 9: 46-50, 1996.
Chung S.M., Ralston E.L.
Necrosis of the femoral head associated with sickle-cell anemia and its genetic variants. A review of the literature and study of thirteen cases.
J. Bone Joint Surg., 51A: 33-58, 1969.
Chung S.M., Ralston E.L.
Necrosis of the humeral head associated with sickle-cell anemia and its genetic variants.
Clin. Orthop. Rel. Res., 80: 105-117, 1971.
Chung S.M., Alavi A., Russsel M.O.
Management of osteonecrosis in sickle cell anemia and its genetic variants.
Clin. Orthop., 130: 158-174, 1978.
Clark M.R., Mohandas N., Shohet S.B.
Deformability of oxygenated irreversibly sickled cells.
J. Clin. Invest., 65: 189-196, 1980.
Conley C.L., Weatherall D.J., Richardson S.N., Shepard M.K., Charaches S.
Hereditary persistence of foetal hemoglobin: a study of 79 affected persons in 15 negro families in Baltimore.
Blood, 21: 261-268, 1963.
Cook J.E., Meyer J.
Severe anemia with remarkable elongated and sickle-shaped red blood cells and chronic leg ulcer.
Arch. Int. Med., 16: 644-651, 1915.
Cooley T.B., Witwer E.R., Lee P.
Anemia in children with splenomegaly and peculiar changes in the bones.
Amer. J. Dis. Child., 34: 347-363, 1927.
Cooley T.B., Lee P.
The role of erythrocyte fragmentation in the genesis of anemia.
J. Ped., 55-63, 1933.
Cornu G.
Bone Marrow transplantation in five children with sickle cell anemia.
Lancet, 1: 1427-1428, 1988.
Coutelier L.
Nécrose aseptique de la tête fémorale due à a drépanocytose et à l'ostéochondrite dissecante dans la race noire.
Ann. Soc. Belge de Méd. Trop., 46: 289 -300, 1966
Croiza T.H.
Circulating cytokines in sickle cell patients during steady state.
Br. J. Haematol., 87:592-597, 1994.
Curtin P.D., Vansina J.
Sources of the nineteenth century Atlantic slave trade.
J. African History, 2: 185-208, 1964.
Curtin P.D.
The atlantic slave trade: a census.
University of Wisconsin Press, Madison, pp. 338, 1969.
http://www.isto.org/stable/pdfplus/30145858.pdf
Cynober T., Mielot F., Schischmanoff P.O., Delaunay J., Tchernia G.
La sphérocytose héréditaire.
Rev. Francaise Lab., 324, 45-49, 2000.
Dahmani O., Belcaid A., El Azzouzi O., El Hami H.
Biosynthèse et rôle physiologique de l’hémoglobine.
www.chufes.ma/amirf/Cours/biologie/12.pdf (consulté le 20.12.2009)
de Ceulaer K., Forbes M., Roper D., Serjeant G.R.
Non-gouty arthritis in sickle-cell disease: report of 37 consecutive cases.
Ann. Rheum. Dis., 43: 599-603, 1984.
de Gheldere A., Ndjoko R., Docquier P-L., Mousny M., Rombouts J-J.
Orthopaedic complications associated with sickle-cell disease.
Acta Orthop. Belg., 72: 741-747, 2006.
de Montalembert M., Tshilolo L.
Les progrès thérapeutiques dans la prise en charge de la drépanocytose sont-ils applicables en Afrique subsaharienne?
Méd. Trop., 6: 612-616, 2007.
de Sèze S., Welfling J., Lequesne M.
L’ostéonécrose primitive de la tête fémorale chez l’adulte.
Rev. Rhum. Mal. osteoartic., 27: 117-127, 1960.
Decastel M., Leborgne-Samuel Y., Alexandre L., Mérault G., Berchel C.
Morphological features of the human umbilical vein in normal, sickle cell trait, and sickle cell disease pregnancies.
Hum. Path., 30: 13-20, 1999.
Delaunay C., Le Ballc’h T., Mazas F.
Ostéo-nécrose aseptique non traumatique de la tête fémorale. Considérations éthiopathogéniques évolutives et thérapeutiques. Revue de la littérature.
Rev. Chir. Orthop., 72, 127-138, 1986.
Delaunay J., Bolvin P.
Le squelette du globule rouge.
La Recherche, 223: 844-852, 1990.
Desai D.V., Dhanani H.
Sickle cell disease: history and origin.
The Internet Journal of Hematology, Vol. 1: Numb 2, 2004.
Diagne I., Badiane M., Moreira C., Signate-Sy H., Ndiaye O., Lopez-Sall P., Preira-Sylla G., Camara B., Diouf S., Diack-Mbaye A., Fall M.
Lithiase biliaire et drépanocytose homozygote en pédiatrie à Dakar (Sénégal).
Arch. Pédiatr., 6: 1286-1292, 1999.
Diarra J.P.
Etude rétrospective de 223 enfants drépanocytaires suivis à l’hôpital de Pointe-à-Pitre.
Thèse de Médecine, Université de Bordeaux II, pp. 179, 1990.
Diarra J.P., Bibrac A., Saint-Martin C., Kéclard L., Etienne-Julan M.
Intérêt de la prise en charge de la drépanocytose: expérience de la Guadeloupe, 303-316, 2003.
In: "La Drépanocytose", R. Girot, P. Bégué, F. Galacteros, Eds., J. Libbey Eurotext Pub., Paris, pp. 321, 2003.
Dickerson R.E., Geis I.
Hemoglobin: structure, fonction, evolution and pathology.
Bejamin/Cumming, Menlo Park, Calif., pp. 176, 1983.
Diggs L.W., Ching R.E.
Pathology of sickle cell anemia.
Southern Med. J., 27: 839-845, 1934.
Diggs L.W.
Bone and joint lesions in sickle-cell disease.
Clin. Orthop. Relat. Res., 52: 119-143, 1967.
Dihlmann W.
CT analysis of the upper end of the femur: the asterisk sign and ischaemic bone necrosis of the femoral head.
Skeletal. Radiol., 8: 251-258; 1982.
Dimeglio A., Allouche A.
Le Syndrome de Legg-Perthes-Calvé.
In: "La hanche pédiatrique", J.G. Pous, Ed., Masson, Paris, 114-122, 1987.
Diop S., Koffi G., N'dahtz E., Allangba O., Aka Adjo M.A., Sanogo I., Sangare A.
Profil infectieux chez le drépanocytaire.
Bull. de la Société de Pathologie Exotique, Vol: 90, p. 339-341, 1997.
Diop S., Thiam D., Séné A., Cissé M., Fall K., Touré-Fall A.O., Sow O., Diakhaté L.L.
Association drépanocytose-déficit en G-6-PD: prévalence et influence sur le profil évolutif.
Méd. Afr. Noire, 47: 322-326, 2002.
Diop S., Mokono S.O., Ndiaye M., Touré Fall A.O., Thiam D., Diakhaté L.
La drépanocytose homozygote après l’âge de 20 ans: suivi d’une cohorte de 108 patients au CHU de Dakar.
Rev. Méd. Interne, 24: 711-715, 2003.
Doppelt E., de la Roque F., Morrier Y., Reinert P.H.
L'ostéomyélite chez le drépanocytaire.
Arch. Fr. Pédiatr., 47: 715-720, 1990.
Dorn-Beineke A., Frietsch T.
Sickle cell disease: pathophysiology, clinical and diagnostic implications.
Clin. Chem. Lab. Med., 40: 1075-1084, 2002.
Dossou-Dogass E.
Manifestation osseuses de la drépanocytose: à propos de 19 cas cliniques.
Thèse Université de Paris Nord, n°11, pp. 130, 1986.
Dreyfus B.
Hématologie.
Flammarion Médecine-Sciences, ed, Paris, pp. 771, 1994.
Driss F.
La drépanocytose.
http://www.drepan-hope.com/pages/drepa.php (consulté le 26.10.2009)
Dubart A., Goossens M., Beuzard Y., Monplaisir N., Testa U., Basset P., Rosa J.
Prenatal diagnosis of hemoglobinopathies: comparison of the results obtained by isoelectric focusing of hemoglobins and by chromatography of radioactive globin chains.
Blood, 56: 1092-1099, 1980.
Ducuing J., Marques P., Baux R., Paille J., Voisin R.
Physiologie de la circulation osseuse.
J. Radiol., 32: 713-719, 1951.
Dumarey M., Martin P., Jayankura M., Putz P., Verhas M., Peretz A.
A ‘made in one piece’ skeleton in a 22-year-old man suffering from sickle cell anemiae.
Clin. Rheumatol., 19: 287-290, 2000.
Durroux R., Arlet J.
Critiques de signes histologiques de nécrose osseuse.
Rhumatol., 23: 309-311, 1971.
Dutoit M.
La maladie de Legg-Perthes-Calvé: challenge étiologique, thérapeutique et pronostic.
Arch. Pédiatr., 14: 109-115, 2007.
Eaton J.W., Jacob H.S., White J.G.
Membrane abnormalities of irreversibly sickle cells.
Semin. Hematol., 16: 52-64, 1979.
Ebong W.W.
Acute osteomyelitis three years after a closed fracture in an adult with sickle-cell anemia.
J. Bone Joint Surg., 62A: 1196-1198, 1980a.
Ebong W.W.
The treatment of severely III patients with sickle-cell anemia and associated septic arthritis.
Clin. Orthop. Rel. Res., 149: 145-152, 1980b.
Ebong W.W.
The treatment of chronic osteomyelitis in sickle cell anemia.
Int. Surg., 67: 361-365, 1982.
Ebong W.W.
Pathological fracture complicating long bone osteomyelitis in patients with sickle-cell disease.
Pediatr. Orthop., 6: 177-181, 1986.
Edwards M.H.
Leçons sur la physiologie et l'anatomie comparée de l'homme et des animaux.
Masson, Paris, Vol 1: 36-67, 1857-1883.
Eisinger J., Flores J., Salhany J.M.
Association of cytosol hemoglobin with the membrane in intact erythrocytes.
Proc. Natl Acad. Sci., 79: 408-412, 1982.
Ekeke G.I., Shode F.O.
Phenylalanine is the predominant antisickling agent in cajanus cajan sed extract.
Planta Medicina, 56: 41-42, 1990.
Elekwa I., Monanu M.O., Anosike E.O.
Effects of aqueous extracts of Zanthoxylum macrophylla roots on membrane stability of human erythrocytes of different genotypes
Biokemistri, 17, 7-12 , 2005.
Elira-Dokekias A.
Étude analytique des facteurs d’aggravation de la maladie drépanocytaire au Congo.
Méd. Afr. Noire, 43: 279-285, 1996.
Elira-Dokekias A., Nzingoula S.
Profil du sujet drépanocytaire homozygote après l’âge de 30 ans.
Méd. Afr. Noire, 48: 411-418, 2001.
Elion J., Labie D.
Bases physiopathologiques moléculaires et cellulaires du traitement de la drépanocytose.
Hématologie, 2: 499-510, 1996.
El-Sabbagh A.M., Kamel L.
Avascular necrosis of temporomandibular joint in sickle cell disease.
Clinical rheumatology., 8: 393-397, 1989.
Emmel V.E.
A study of the erythrocyte in a case of severe anemia with elongated and sickle-shaped red blood corpuscles.
Arch. Int. Med., 20: 586-598, 1917.
Esseltine D.W., Baxter M.R.N., Bevan J.C.
Sickle cell states and the anaesthetist.
Can. J. Anaesth., 35: 385-403, 1988.
Etienne-Julan M., Belloy M.S., Decastel M., Dougaparsad S., Ravion S., Hardy-Dessources M.D.
Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8.
Haematologica, 89: 863-864, 2004.
Evans E., Mohandas N., Leung A.
Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.
J. Clin. Invest., 73: 477-488, 1984.
Eyenga V., Eloundou Ngah, Ngowe M., Ze Minkande J., Tchokoteu P.F., Sosso M.
Une complication neurochirurgicale rare de la drépanocytose: l’hématome extra dural spontané.
Méd. Afr. Noire, 48: 378-380, 2001.
Fairbanks G., Steck T.L., Wallach D.E.H.
Electrepheretic analysis of the major polypeptides of the human erythrecyte membrane.
Biochemistry, 10: 2606-2617, 1971.
Fargot-Largeault A.
Les pratiques réglementaires de la recherche clinique.
Méd. Sci., 16: 1198-1202, 2000.
Faure J., Moreno M.
Retentissements psychologiques de la drépanocytose.
In: "La Drépanocytose", R. Girot, P. Bégué, F. Galacteros, Eds., J. Libbey Eurotext Pub., pp. 321, 2003.
Feldman S.D., Tauber A.I.
Sickle cell anemia: reexamining the first "molecular disease"
Bull. History Med., 71: 623-650, 1997.
Ferster A., Tahiri P., Vermylen C., Sturbois G., Corazza F., Fondu P., Devalck C., Dresse M.F., Feremans W., Hunninck K., Toppet M., Philippet P., Van Geet C., Sariban E.
Five years of experience with hydroxyurea in children and young adults with sickle cell disease.
Blood , 97: 3628-3632, 2001.
Ficat P., Utheza G.
Le forage-biopsie de la hanche.
Rev. Med., Toulouse, 9: 223-230, 1968.
Ficat P., Arlet J.
Ischémie et nécrose osseuses. L’exploration fonctionnelle de la circulation osseuse et ses applications.
Ed. Masson, Paris, pp. 220, 1977.
Ficat P., Grijalvo P.
Résultats à long terme du forage-biopsie pour les ostéonécroses de la tête fémorale aux stades I et II.
A propos de 113 cas revus après un délai de 9 ans et 6 mois.
Rev. Chir. Orthop., 70: 253-255, 1984.
Flouzat-Lachaniete J.C., Rossignol X., Poignard A., Mukisi-Mukasa M., Manicom O., Hernigou Ph.
Multifocal joint osteonecrosis in sickle celle disease.
Open Orthop. J., 3: 32-35, 2009.
Friedman M. J.
Erythrocytic mechanism of sickle-cell resistance to malaria.
Proc. Nat. Acad. Sci., USA, 75: 1994-1997, 1978.
Galacteros F.
Bases physiopathologiques de la drépanocytose, prise en charge et actualités thérapeutiques.
Bull. Soc. Pathol. Exot., 94: 77-79, 2001.
Gamaniel K., Samuel B.B., Kapu D.S., Samson A., Wagner H., Okogun, J.I., Wambebe C.
Anti-siclikng, analgesic and anti-inflamatory proprietes of 3,5-dimethoxy-4-hydroxy benzoic acide and 2,3,4- trihydroxyacetophenone.
Phytomedecine, 7: 105-110, 2000.
Gangji V., Hauzeur J.P.
Cellular-based therapy for osteonecrosis.
Orthop. Clin. North AM., 40: 213-221, 2009.
Gaston M.H., Verter J.I., Woods G., Pegelow C., Kelleher J., Presbury G., Zarkowsky H., Vichinsky E., Iyer R., Lobel J.S. , Diamond S., Holbrook T., Gill F.M., Ritchey K., Faetta J.F.
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.
N. Engl. J. Med., 314: 1593-1599, 1986.
Gardeniers J.W.M.
Report of the Committee of Staging and Nomenclature.
ARCO News Letter, 5: 79-82, 1993.
Geller A.K., O’Connor M.K.
The sickle cell crisis: a dilemma in pain relief.
Mayo Clin. Proc., 83: 320-323, 2008.
http://www.mayoclinicproceedings.com/content/83/3/320.full.pdf+html (consulté le 24.12.2009).
Gerald B., Sebes J.I., Langston J.W.
Cerebral infarction secondary to sickle cell disease: arteriographic findings.
AJR 134: 1209-1212, 1980.
Gires F., Leroy-Willig A., Chevrot A., Giraud B.
L’ostéonécrose de la tête fémorale. Etude par IRM de 60 cas.
J. Radiol., 68: 503-510, 1987.
Girot R., Galacteros F., Lena-Russo D.
Dépistage néo-natal de la drépanocytose en France métropolitaine.
Colloque CIE-INSERM, 21-30, 1990.
Girot R., Bégué P., Galacteros F.
La drépanocytose.
J. Libbey Eurotext Limited, Paris, pp. 321, 2003.
Girot R.,Lionnet F.
La drépanocytose: de l'enfance à l'âge adulte.
Arch. de pédiatrie, 14: 605-606, 2007.
Gnassingbe K., Akakpo-Numado G.K., Attipou K., Gbadoe A., Tekou H.
Peut-on envisager une splénectomie préventive des complications des splénomégalies chez l’enfant drépanocytaire?
Cahiers d'études et de recherches francophones / Santé, 17: 207-211, 2007.
http://www.john-libbey-eurotext.fr/fr/revues/sante_pub/san/e-docs/00/04/3A/01/article.phtml (consulté le 11.02.2010).
Godefroy D., Chevrot A., Morvan G., Rousselin B., Sarazin L.
Les clichés simples du bassin.
J. Radiol., 89: 679-691, 2008.
Goldberg M.F.
Classification and pathogenesis of proliferative sickle retinopathy.
Am. J. Ophtalmol., 71: 649-665, 1971.
Goldstein A.R., Anderson M.J., Serjeant G.R.
Parvovirus associated aplastic crisis in homozygous sickle cell disease.
Arch. of Dis. Child., 62: 585-588, 1987.
Gormley M.
It’s in the blood. The varieties of Linus Pauling’s work on hemoglobin and sickle cell anemia.
MS thesis submitted to Oregon State University, pp. 196, 2003.
Graham G.S.
A case of sickle cell anemia with necropsy.
Arch. Int. Med., 34: 778-800, 1924.
Greenberg M.S., Kass E.H., Castle W.B.
Studies on the destruction of red blood cells. Factors influencing the role of S hemoglobin in the pathologic physiology of sickle cell anemia and related disorders.
J. Clin. Invest., 36: 833-843, 1957.
Guedj F.
Lésions ostéoarticulaires au cours de la drépanocytose.
Thèse pour le Doctorat en Médecine (diplôme d'état), Université Paris VII, n°206, pp. 64, 1990.
Guerci-Bresler A.
Syndromes myélodysplastiques. Place de chélation du fer et optimisation du suivi thérapeutique.
Hématol., 15: 3-9, 2009.
Gulbis B., Tshilolo L, Cotton F., Lin C, Vertongen F.
Newborn screening for haemoglobinopathies: the Brussels experience.
J. Med. Screen, 6: 11-15, 1999.
Gulbis B., Ferster A., Kentos A., N’Gay Munungi D., Cotton F., Rongé E., Dresse M.F., Bradstreet C., Cochaux P., Vertongen F.
La drépanocytose: une affection exotique ou un problème de santé publique en Belgique.
Rev. Méd. Brux., 26: S309-313, 2005.
Habermann E.T., Grayzel A.I.
Bilateral total knee replacement in a patient with sickle-cell disease.
Clin. Orthop., 100: 211-215, 1974.
Habibi A., Bachir D., Godeau B.
Complications aiguës de la drépanocytose.
Revue du Praticien, 54: 1548-1556, 2004.
Haenisch F.
Arthritis dissecans der Hüfte.
Zentralblatt für Chir., 52: 999, 1925.
Hahn, E.V., Gillespie E.B.
Sickle-cell anemia. Report of a case greatly improved by splenectomy; experimental study of sickle-cell formation.
Arch. Int. Med., 39: 233-254, 1927.
Hamburg A.E.
Skeletal changes in sickle-cell anaemia.
J. Bone Joint Surg., 32A: 893-900, 1950.
Hammer M., Geier K.A., Akosy S.
Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis.
Orthop. Nurs., 22: 384-397, 2003.
Hanker G.J., Amstutz H.C.
Osteonecrosis of the hip in the sickle-cell disease. Treatments and complications.
J. Bone Joint Surg., 70A: 499-506, 1988.
Hansen G.C., Gold R.H.
Central depression of multiple vertebral end-plates: a "pathognomonic" sign of sickle hemoglobinopathy in Gaucher's disease.
Am. J. Roentgenol., 129: 343-344, 1974.
Hansen V., Gulbis B., Cotton F., Vertongen F.
Quelques informations écrites sur les hémoglobinopathies.
Laboratoire de Chimie hématologique - Hôpital Erasme, pp. 4, mai 2000.
http://erasmeinfo.ulb.ac.be/globule/Doc/topo2.pdf
Harris J.W.
Studies on the destruction of red blood cells: molecular orientation in sickle-cell hemoglobin solution.
Proc. Soc. Exper. Biol. Med., 75: 197-201, 1950.
Harroche-Angel A.
Ostéonécrose et drépanocytose.
Thèse de doctorat en Médecine, Université Pierre et Marie Curie, Paris VI, pp. 105, 2007.
Hasan S.P., Hashmi S., Alhassen M., Lawson W., Castro O.
Depression in sickle cell disease.
J. Natl. Med. Assoc., 95: 533-537, 2003.
Hauzeur J.P., Orloff S., Taverne-Verbanck J., Pasteels J.L.
Diagnosis of aseptic osteonecrosis of the femoral head by percutaneous transtrochanterien needle biopsy.
Clin. Rheumatol., 5: 346-348, 1986.
Hauzeur J.P., Pasteels J.L., Orloff S.
Bilateral non-traumatic aseptic osteonecrosis in the femoral head.
J. Bone Joint Surg., 69A: 1221-1225, 1987.
Hauzeur J.P., Pasteels J.L., Schoutens A., Hinsenkamp M., Appelboom T., Chorchard I., Perlmutter N.
The diagnostic value of magnetic resonance imaging in non-traumatic osteonecrosis in the femoral head.
J. Bone Joint Surg., 71A: 641-649, 1989.
Hauzeur J.P., Sintzoff J., Pasteels J.L., Appelboom T., De Maertelaer V., Bentin J., Pasteels J.L.
Relationship between magnetic resonance imaging and histologic finding by biopsy in nontraumatic osteonecrosis of the femoral head.
J. Rheumatol., 19: 385-392, 1992.
Havinga E., Itano H.A.
Electrophoretic studies of globins prepared from normal adult and sickle-cell hemoglobins.
Proc. Natl. Acad. Sci. 39: 65-67, 1953.
Hawker H., Neilson H., Hayes R.J., Serjeant G.R.
Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease.
Br. J. Haematol., 50: 29-34, 1982.
Hebbel R.P., Yamada O., Moldow C.F., Jacob H.S., White J.G., Eaton J.W.
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease.
J. Clin. Invest., 65: 154-160, 1980.
Hebbel R.P.
Beyond haemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology.
Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity Blood, 77: 214-237, 1991.
Hernigou Ph., Voisin M.C., Despres E., Goutalier D.
Confrontation de l'imagerie par résonance magnétique nucléaire et de l’histologie dans les nécroses des têtes fémorales.
Rev. Rhum. Mal. osteoartic., 56: 741-744, 1984.
Hernigou Ph., Galacteros F., Bachir D., Goutalier D.
Histoire naturelle de la nécrose de la hanche dans la maladie drépanocytose. A propos de 104 cas.
Rev. Chir. Orthop., 75: 542-557, 1989.
Hernigou Ph., Galacteros F., Bachir D., Goutalier D.
Deformities of the hip in adults who have sickle cell disease and avascular necrosis in childhood. A natural history of fifty-two patients.
J. Bone Joint Surg., 73A: 81-92, 1991.
Hernigou Ph., Bachir D., Galacteros F.
Avascular necrosis of the humeral head in sickle-cell disease.
J. Bone Joint Surg., 75B: 875-880, 1993.
Hernigou Ph. Bernaudin F.
Evolution du tissus après allogreffe de la moelle osseuse chez l’adolescent drépanocytaire.
Rev. Chir. Orthop., 80: 138-143, 1994.
Hernigou Ph., Bernaudin F., Reinert P., Kuentz M., Vernant J.P.
Bone marrow transplantation in sickle cell disease; effect on osteonecrosis.
J. Bone Joint Surg., 79A: 1726-1730, 1997.
Hernigou Ph.
Autologous bone marrow grafting of vascular osteonecrosis before collapse.
Rev. Rhum., 65: 79-84, 1998.
Hernigou Ph., Lambotte J.C.
Bilateral hip osteonecrosis. influence of hip size on outcome.
Ann. Rheum. Dis., 59: 817-821, 2000.
Hernigou Ph., Habibi A., Bachir D., Galacteros F.
The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease.
J. Bone Joint Surg., 88A: 2573-2582, 2006.
Hernigou Ph., Daltro G., Filipini P., Mukisi Mukasa M., Manicom O.
Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease.
Open Orthop. J., 2: 75-78, 2008a.
Hernigou Ph., Zilber S., Filippini P., Mathieu G., Poignard A., Galacteros F.
Total hip arthroplasty (THA) in adult osteonecrosis related to sickle cell disease.
Clin. Orthop. Relat. Res., 466: 300-308, 2008b.
Herrick J.B.
Peculiar elongated and sickle-cell shaped red blood corpuscles in a case of severe anemia.
Arch. Int. Med., 6: 517-521, 1910.
Herz F., Kaplan E., Scheye E.S.
Diagnosis of erythrocyte Glucose-6-Phosphate Dehydrogenase deficiency in the negro male despite hemolytic crisis.
Blood, 35: 90-93, 1970.
Hinsenkamp M., Hauseur J.P., Sintzoff S.Jr.
Long term results in electromagnetic fields (EMF) treatment of osteonecrosis.
In: Bone circulation and vascularization in normal and pathological conditions, NATO science series,
A. Schoutens, J. Arlet, J.W.M. Gardeniers, S.P.F. Hughes, Eds., Plenum press Pub., New York, 331-336, 1993.
Hittmair K., Hofmann S., Breitenseher M., Leder K., Rottmann B., Kramer J., Engel A.
Diagnostic value of CT in avascular necrosis of the femoral head.
Arco News Letter, 7: 83-84, 1995.
Hofrichter J., Ross P.D., Eaton W.A.
Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease.
Proc. Nat. Acad. Sci., 71: 4864-4868, 1974.
Holzman L., Finn H., Lichtman H.C., Harmel M.H.
Anesthesia in patients with sickle cell disease: a review of 112 cases.
Anesth. Analg., 48: 566-572, 1969.
Homawoo K., Bissang K., Songne B., Ayite A.
Drépanocytose et ostéonécrose de la tête fémorale. Considérations thérapeutiques. A propos de 38 cas.
Méd. Afr. Noire, 38: 510-517, 1991.
Horne M.K.
Siclkle cell anemia as rheologic disease.
Am. J. Med., 70: 288-298, 1981.
Horton J.A.B.
The diseases of tropical climates and their treatment.
Churchill Pub., London, 477-498, 1874.
Globin Gene Server.
http://globin.cse.psu.edu/ (consulté le 20.11.09).
Huck, J.G.
Sickle-cell anemia.
Bull. Johns Hopkins Hosp., 34: 335-344, 1923.
Huehns E.R.
Diseases due to abnormalities of hemoglobin structure.
Annu. Rev. Med., 21: 157-178, 1970.
Huisman T.H.J., Altay C., Webber B., Reese A.L., Gravely M.E., Okonjo K., Wilson J.B.
Quantitation of three types of gamma chain of HbF by high pressure liquid chromatography; application of this method to the HbF of patients with sickle cell anemia or the S-HPFH condition.
Blood, 57: 75-82, 1981.
Hungerford D.S.
Early diagnosis of ischemic necrosis of the femoral head.
Bull. John Hopkins Med. J., 13: 270-275, 1975.
Huskisson E.C.
Measurement of pain.
Lancet, 304: 1127-1131, 1974.
IHIC: International Hemoglobin Information Center Policies.
Variants of the alpha, beta and gamma chains.
Hemoglobin, 10: 259-351, 1986.
Ingram V.M.
A specific chemical difference between globins of normal and sickle-cell anemia hemoglobins.
Nature, 178: 792-794, 1956.
Ingram V.M.
Hemoglobin and its abnormalities.
Charles Thomas Pub., I.N. Kugelmass, Ed., Springfield, Illinois, pp. 153, 1961.
Innvista
Sickle cell history.
http://www.innvista.com/health/ailments/anemias/sickhist.htm (consulté le 18.01.2007).
Itano H.A., Pauling L.
A rapid diagnostic test for sickle cell anemia.
Blood, 4: 66-68, 1949.
Itano H.A.
Solubilities of naturally occurring mixtures of human haemoglobin.
Arch. Biochem. Biophys., 47: 148-149, 1953.
Itano H.A.
Specificity in the interaction of sickle cell haemoglobin, molecules.
In: "Molecular structure and biological specificity", L. Pauling, H.A. Itano Eds., American Institute of Biological Sciences, Washington, D.C., 166-173, 1957.
Jean-Baptiste G., de Ceulaer K.
Actualité des manifestations rhumatologiques des hémoglobinopathies.
Revue du Rhumatisme, 70: 157-161, 2003.
Jeong G.K., Ruchelsman D.E., Jazrawi L.M., Jaffe W.L.
Total hip arthroplasty in sickle cell hemoglobinopathies.
Am. Acad. Orthop. Surg., 13: 208-217, 2005.
Jonhson F.L., Look A.T., Gokerman J.
Bone marrow transplantation in a patient with sickle-cell anemia.
N. Eng. J. Med., 311: 780-783, 1984.
Kabakele K.M.
Contribution au diagnostic précoce de l'ostéonécrose drépanocytaire.
Thèse d'agrégation, Faculté de Médecine, Université de Kinshasa, Presses Universitaires du Zaïre, pp. 124, 1974.
Kan Y.W.
Prenatal diagnosis of haemoglobin disorders.
Progr. Hemat., 10: 91-104, 1977.
Kan Y.W., Dozy A.M.
Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells.
Lancet, 910-911, 1978a.
Kan Y.W., Dozy A.M.
Polymorphism of DNA sequence adjacent to human β-globin structural gene: relationship to sickle mutation.
Proc. Natl. Acad. Sci. U.S.A., 75: 5631-5635, 1978b.
Kattamis C., Kanavakis E., Tzotzos S., Synodinos J., Metaxotou-Mavrommati A.
Correlation of clinical phenotype to genotype in haemoglobin H disease.
Lancet, 1: 442-444, 1988.
Kaul D.K., Fabry M.E., Nagel R.L.
Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions.
Pathophysiological implications.
Proc. Natl. Acad. Sci., 86: 3356-3360, 1989.
Kaul D.K., Tsai H.M., Liu X.D., Nakada M.T., Nagel R.L., Coller B.S.
Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions.
Blood, 95: 368-374, 2000.
Kaul D.K.
"Stress" and sickle red cell adhesion.
Blood, 104: 3425-3426, 2004.
Kazazian H.H., Phillips J.A., Boehm C.D., Vik T.A., Mahoney M.J., Ritchey A.K.
Prenatal diagnosis of beta-thalassemias by amniocentesis: linkage analysis using multiple polymorphic restriction
endonuclease sites.
Blood, 56: 926-930, 1980.
Kéclard L., Ollendorf V., Berchel C., Loret H., Mérault G.
βs haplotypes, α-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.).
Hemoglobin, 20: 63-74, 1996.
Kiaer T., Grønlund J., Sørensen K.H.
Subchondral pO2, pCO2, pressure, pH, and acetate in human osteoarthritis of the hip.
Clin. Orthop., 149-155, 1988.
Kiaer Th., Pedersen N.W., Kristensen D., Starklint H.
Intra-osseous pressure and oxygen tension in avascular necrosis and osteoarthritis of the hip.
J. Bone Joint Surg., 72B: 1023-1030, 1990.
Konotey-Ahulu F.I.D.
Hereditary qualitative and quantitative erythrocyte defects in Ghana: an historical and geographical survey.
Ghana Med., 7: 118-119, 1968.
Koo K.H., Kim R.
Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI.
J. Bone Joint Surg., 77B: 875-880, 1995.
Koren A., Garty I., Katzuni E.
Bone infraction in children with sickle-cell anemia.
Eur. J. Pediatr., 142: 93-97, 1984.
Koshy M., Entsuah R., Koranda A., Kraus A.P., Johnson R., Bellevue R., Flournoy-Gill Z., Levy P.
Leg ulcers in patients with sickle cell disease (see comments)..
Blood, 74: 1403-1408, 1989.
Kouamé-Koutouan A., Aboukoua-Kouassi N., Koffi D., Méité M., Sanogo I., Séry J.M.
Nouvelle stratégie dans le diagnostic, la prévention et le suivi de l’ostéonécrose drépanocytaire en Côte d’Ivoire à partir de la scintigraphie osseuse.
Médecine Nucléaire, 33: 604-608, 2009.
Kuntz J.L., Asch L.
Ostéocondensation diffuse au cours de la drépanocytose.
Rev. Rhum., 45: 145-149, 1978.
Labie D., Elion J.
L'endothélium vasculaire, composante majeure de la maladie drépanocytaire: les cellules circulantes en sont le reflet.
Médecine/Science, 14: 352-355, 1998.
Lambotte-Legrand J., Lambotte-Legrand C.
L'anémie à hématies falciformes chez l'enfant indigène du Bas-Congo. Etude génétique, clinique et hématologique basée sur 88 cas.
Mémoires, Institut Royal Colonial belge (section des sciences naturelles), fasc. 7: 19-31, 1951.
Lambotte-Legrand C.
Hand foot syndrome in sickle-cell disease.
Amer. J. Dis. Child., 104: 200-200, 1962.
Lard L.R., Mul F.P., de Hass M., Roos D., Duits A.J.
Neutrophil activation in sickle cell disease.
J. Leukocyte Biol., 66: 411-415, 1999.
Laredo J., Chicheportiche V., Naouri J.F., Tubiana J.M.
L'IRM dans les ostéonécroses aseptiques de la tête fémorale: revue de la littérature.
Ann. Radiol., 36: 94-104, 1993.
Laroche M.
Circulation intra-osseuse de la physiologie à la pathologie.
Rev. Rhum., 69: 484-91, 2002.
Larsen R.M.
Intramedullary pressure with particular reference to massif diaphyseal bone necrosis. Experimental observations.
Ann. Surg., 108: 127-140, 1938.
Lasserre P.
Singaravelou, les Indiens de la Guadeloupe.
Ann. de Géog., 86: 366-368, 1977.
Lavinha J., Gonçalves J., Faustino P., Romão L., Osório-Almeida L., Peres M.J., Picanço I., Martins M.C., Ducrocq R., Labie D.
Importation route of the sickle cell trait into Portugal: contribution of molecular epidemiology.
Hum. Biol., 64: 891-901, 1992.
Le Turdu-Chicot C., Foucan L., Etienne-Julan M.
Séroprévalence virale, transfusion et allo-immunisation chez des adultes drépanocytaires guadeloupéens.
Transfus. Clin. Biol., 9: 115-1120, 2002.
Leachman R.D., Miller W.T., Atias I.M.
Sickle cell trait by sickle cell trait complicated by sickle cell thrombi after open-heart.
Am. Heart J., 74: 268-271, 1967.
Lebby R.
Case of absence of the spleen.
South. J. M. & Pharm., (Charleston), 1: 481-483, 1846.
Leborgne-Samuel Y., Janky J., Venditelli F., Salin J., Daijardin J.B., Couchy B., Etienne-Julan M., Berchel C.
Drépanocytose et grossesse: revue de 68 observations en Guadeloupe.
J. Gynec. Obstet. Reprod., 29: 86-93, 2000.
Leboulch P., Huang G.M., Humphries R.K., Oh Y.H., Eaves C.J., Tuan D.Y., London I.M.
Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure.
EMBO. J., 13: 3065, 1994.
Lena-Russo D., North M.L., Girot R.
Epidémiologie des maladies génétiques de l’hémoglobine en France Métropolitaine.
Rev. Prat., 42: 1867-1872, 1992.
Lequesne M., Mery C., Samson M., Gérard P.
Indexes of severity for osteoarthritis of the hip and knee.
Scand. J. Rheumatol., 65: 85-89, 1987.
Lequesne M.
Hanches douloureuses de l’adulte à radiographies standard normales ou non probantes.
In: "Evaluation Radiologique de l’Imagerie de l’Appareil Locomoteur";
Sauramps Ed., Paris, 93-97, 1994.
Leleu J.P., Joulie M., Cuismer R., Dehais J.
Manifestations ostéo-articulaires de la drépanocytose.
Sem. Hop. Paris, 63: 2483-2489, 1987.
Lepage P., Dresse M.F., Forget P., Schmitz V.
Infections et prophylaxies anti infectieuses dans la drépanocytose.
Rev. Méd. de Liège, 59: 145-148, 2004.
Levêque A.
Méthodes de base en épidémiologie.
Presses Universitaires de Bruxelles, pp. 110, 2009.
Lewis R.A., Kay R.W., Hathon M.
Sickle cell disease and glucose-6-phosphate dehydrogenase.
Acta haemat., 36: 399-411, 1966.
Lewis M.R., Gross L.J., Josephs R.
Cryo-electron microscopy of deoxy-sickle hemoglobin fibers.
Micro. Res. Tech., 27: 459-467, 1994.
Li J., Lykotrafitis G., Dao M., Suresh S.
Cytoskeletal dynamics of human erythrocyte.
Proc. Natl. Acad. Sci., 104: 4937-4942, 2007.
Lian C.C., Roth S., Harkness D.R.
The effect of alteration of intra-cellular 2,3 DPG concentration upon oxygen binding of intact erythrocytes containing normal and mutant hemoglobins.
Biochem. Biophys. Res. Commun., 45: 151-158, 1971.
Lieberman J.R., Daluiski A., Einhorn T.A.
The role of growth factors in the repair of bone biology and clinical applications.
J. Bone Joint Surg., 84A: 1032-1044, 2002.
Linderkamp O., Meiselman H.J.
Geometric, osmotic, and membrane mechanical properties of density-separated human red cells.
Blood, 59: 1121-1127, 1982.
Lionnet F., Arlet J.B., Bartolucci P., Habibi A., Ribeil J.A., Stankovic K.
Recommandations pratiques de prise en charge de la drépanocytose de l’adulte.
Rev. Méd., 30: 162-223, 2009.
Louis R., Pouye Y., Argenson C.
Les ostéomyélites drépanocytaires chez l’adulte: quatre observations.
Rev. Chir. Orthop., 59: 109-114, 1973.
Lucarelli G., Galimberti M., Polchi P., Giardini C., Polit P., Baronciani D., Angelucci E., Manenti F., Delfini C.
Marrow transplantation in patients with advanced thalassemia.
N. Engl. J. Med., 316: 1050-1055, 1987.
Lux S.E., John K.M., Karnovsky M.J.
Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells J. Clin. Invest., 58: 955-963, 1976.
Luzzatto L.
Genetics of red cells and susceptibility to malaria.
Blood, 54: 961-976, 1979.
Mabiala-Babela J.R.., Massamba A., Tsiba J.B., Moulongo J.G.A., Nzingoula S., Senga P.
Composition corporelle d'enfants drépanocytaires homozygotes congolais. Étude longitudinale à Brazzaville, Congo.
Bull. Soc. Pathol. Exot., 98: 394-399, 2005.
Maillefert J.F., Toubeau M., Piroth C., Piroth L., Brunotte F., Tavernier C.
Bone scintigraphy equipped with a pinhole collimator for the diagnosis of the femoral head.
Clin. Rheumatol., 16: 372-377, 1997.
Malghem J., Maldague B.
Aspects radiologiques des nécroses épiphysaires et implications pathogéniques.
Acta Orthop. Belg., 47: 200-224, 1981.
Maniatis T., Fritsch E.F., Lauer J., Lawn R.M.
The molecular genetics of human hemoglobins.
Annu. Rev. Genet., 14: 145-178, 1980.
Mankad V.N., Williams J.P., Harpen M.D., Manci E., Longenecker G., Moore R.B., Shah A., Yang Y.M., Brogdon B.G.
Magnetic resonance imaging of bone marrow in sickle cell disease: clinical, hematologic, and pathologic correlations.
Blood, 75: 274-283, 1990.
Marin A., Cerutti N., Massa E.R.
Use of the amplification refractory mutation system [ARMS] in the study of HBS in predynastic Egyptian remains.
Boll. Soc. Ital. Biol. Sper., 75: N 5-6: 27-30, 1999.
Martinez S., Apple J.S., Baber C., Putman C.E., Rosse W.F.
Protusio acetabuli in sickle-cell anemia.
Radiology, 151: 43-44, 1984.
Mason V.R.
Sickle cell anemia.
JAMA, 79: 1318-1320, 1922.
Mazières B., Marin F., Chiron P., Moulinier L., Amigues J.M., Laroche M., Cantagrel A.
Influence of the volume of osteonecrosis on the outcome of core decompression of the femoral head.
Ann. Rheum. Dis., 56:747-750, 1997.
McCormack M.K., Dicker L., Katz S., Caleb M., McDaniels J., Humphery A., Buchert E.., Lubin B.
Growth patterns of children with sickle-Cell disease.
Hum. Biol., 48: 429-437, 1976.
McDermot A.G.., Yabsley R.H., Leahey J.L.
A new method to measure intraosseous pressures.
Clin. Orthop. Rel. Res., 208: 25-27, 1986.
Mehta A.B., Hoffbrand A.V.
Hématologie.
Science Médicale, série Claude Bernard, De Boeck Université Eds, pp 208, 2003.
Mérault G., Diarra J.P., De Caunes F., Bibrac A., Loret H., Berchel C., Reinette P.
Dépistage néonatal et prise en charge coordonnée de la drépanocytose en Guadeloupe.
Colloque CIE-INSERM, 31-43, 1990.
Mérault G., Diarra J.P., De Caunes F., Bibrac A., Loret H., Berchel C., Reinette P.
Dépistage néonatal et prise en charge coordonnée de la drépanocytose en Guadeloupe.
In: "Drépanocytose et Santé publique", F. Galacteros, S. Dormont, eds., 31-43, 1991.
Merle d’Aubigné R., Postel M., Mazabraud A., Massias P., Gueguen J.
Idiopathic necrosis of the femoral head in adults.
J Bone Joint Surg., 47B, 612-633, 1965.
Merle d’Aubigné R.
Cotation chiffrée de la fonction de la hanche.
Rev. Chir. Orthop., 56: 481-486, 1970.
Miles J.S.
The use of intramedullary pressure in the early determination of aseptic in the femoral head.
J. Bone Joint Surg., 37A: 622-623, 1955.
Milner P.F., Kraus A.P., Sebes J.L., Sleeper L.A., Dukes K.A., Embury S.H, Bellevue R., Koshy M., Moohr J.W., Smith J.
Sickle cell disease as a cause of ostonecrosis of femoral head.
N. Engl. J. Med., 325: 1476-1481, 1991.
Milner P.F., Kraus A.P., Sebes J.L., Sleeper L.A., Lynn A., Dukes K.A., Embury S.H., Bellevue R., Koshy M., Moohr J.W., Smith J.
Osteonecrosis of the humeral head in sickle cell disease Clin. Orthop. Rel., Res., 289: 136-143, 1993.
Mitchell M.D., Kundel H.L., Steinberg H.Y.
Avascular necrosis of the hip: comparison of MR, CT and scintigraphy.
Am. J. Roentgenol., 147: 67-71, 1986.
Monnet D., Edjeme N.E, Ndri K., Hauhouot-Attoungbre M.L., Ahibo H., Sangare A., Yapo A.E.
La lipoprotéine (a), les protéines de la phase aiguë de l’inflammation au cours de la crise drépanocytaire homozygote.
Ann. Bio. Clin., 60:101-103, 2002
Monplaisir N., Mérault G., Poyart C., Rhoda M.D., Craescu C., Vidaud M., Galacteros F., Blouquit Y., Rosa J.
Hemoglonbin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterezygotes.
Proc. Natl. Acad. Sci., 83: 9363-9367, 1986.
Moran M.C.
Osteonecrosis of the hip in sickle cell hemoglobinopathy.
Am. J. Orthop., 24: 18-24, 1995.
Moran M.C., Huo M.H., Garvin K.L., Pellici P.M., Salvati E.A.
Total hip arthroplastie in sickle cell hemoglobinopathy.
Clin. Orthop. Rel. Res., 294: 140-148, 1993.
Morel C.
Atteinte rétinienne des hémoglobinopathies.
J. Fr. Ophtalmol., 24: 987-992, 2001.
Motulsky A.G.
Frequency of sickling disorders in US blacks.
New Eng. J. Med., 288: 31-33, 1973.
Mpiana P.T., Mudogo V., Tshibangu D.S.T., Ngbolua K.N., Shetonde O.M., Mangwala K.P., Mavakala B.K.
In vitro antisickling activity of antocyanins extract of a congolese plant: alchornea cordifolia.
J. Med. Sci., 7: 1182-1186, 2007
Mukisi-Mukaza M.
Ostéonécrose drépanocytaire. Etude clinique de l’atteinte des os longs.
Mémoire de Licence en Orthopédie Traumatologie, Université Libre de Bruxelles, pp. 221, 1992.
Mukisi-Mukaza M., Elbaz A., Samuel-Leborgne Y., Keclard L., Le Turdu-Chicot C., Christophe-Duchange E., Mérault G.
Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease.
Orthopedics, 23: 357-363, 2000.
Mukisi Mukaza M., Andrianne Y., Burny F., Quintin J., Tshakatumba M.J., Tshilolo L., Pay-Pay N.
Complications ostéo-articulaires de la drépanocytose. Evolution de 35 atteintes diaphysaires des os longs observées chez 29 patients drépanocytaires homozygotes SS.
Méd. Afr. Noire, 50: 532-540, 2003.
Mukisi Mukaza M., Falémé A., Céolin J.M., Roudier M, Le Turdu-Chicot C., Samuel-Leborgne Y.
Conservative surgical treatment of osteonecrosis of the femoral head in sickle cell anaemia patients: outcome at two to ten years in 21 patients treated with drill-biopsy and three treated with the femoral osteotomy.
J. Bone Joint Surg., 87B: Suppl. II: 133, 2005.
Mukisi Mukasa M., Bashoun K., Burny F.
Ostéonécrose drépanocytaire de la tête fémorale et pression intra osseuse.
Rev. Chir. Orthop., 95: 153-157, 2009a.
Sickle-cell hip necrosis and intraosseous pressure.
Orthop. Traumatol. Surg. Res., 95: 134-138, 2009a.
Mukisi-Mukaza M., Manicom O., Fillipini P., Hernigou Ph.. Ostéonécrose du coude dans la drépanocytose (à propos de 6 cas).
Rev. Chir. Orthop., 95: 85-87, 2009b.
Mukisi-Mukaza M., Bashoun K., Manicom O., Alexis C., Donkerwolcke M., Burny F.
Traitement conservateur de l’ostéonécrose drépanocytaire de la tête fémorale par forage simple.
Rev. Chir. Orthop., 95: 601-608, 2009c.
Mukisi Mukaza M., Bashoun K., Manicom O., Alexis C., Donkerwolcke M., Burny F.
Treatment of sickle cell disease’s hip necrosis by core decompression: A prospective case-control study.
Orthop. Traumatol. Surg. Res., 95: 498-504, 2009d.
Murayama M.
Molecular mechanism of red cell "Sickling".
Science, 153: 145-149, 1966.
Näslund J., Pettersson J., Lundeberg T., Linnarsson D., LindbergL.G.
Non-invasive continuous estimation of blood flow changes in human patellar bone.
Med. Bio. Eng. Comp., 44: 501-509, 2006.
Nault J.C., Amathieu R., Luis D., Dhonneur G.
Une insuffisance hépatocellulaire aiguë compliquant une crise vaso-occlusive drépanocytaire.
An. Fr. Anesth. Réanim., 28: 393-339, 2009.
N’Dri K., Messan Ahoure A., Zunon-Kipre E., Konan A., Kouassi N’Zi P., Etti E., Burdin G., Blaguet Abby C.
Aspects radiographiques et tomodensitométriques de la nécrose de la tête fémorale chez le drépanocytaire.
Cahiers d'études et de recherches francophones, 10: 27-30, 2000.
http://www.john-libbey-eurotext.fr/fr/revues/sante_pub/san/e-docs/00/03/5B/6F/article.phtml (consulté le 18.06.10).
Neel J.V.
The inheritance of sickle-cell anemia.
Science, 110: 64-66, 1949.
Neumayr L.D., Aguilar C., Earles A.N., Jergesen H.E., Haberkern C.M., Kammen B.F., Nancarrow P.A., Padua E., Milet M., Stulberg B.N., Williams R.A., Orringer E.P., Graber N., Robertson S.M., Vichinsky E.P.
Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment.
J. Bone Joint Surg., 88A: 2573-2582, 2006.
Noël H., Degels M.A., Coutelier L.
Anatomie pathologique de la nécrose aseptique, idiopathique de la tête fémorale.
Acta Orthop. Belg., 47: 191-197, 1981.
Noguchi C.T., Schechter A.N.
The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease.
Blood, 58: 1057-1068, 1981.
Nosny P., Aubert L., Nosny Y., Caron J.
Complications chirurgicales de la drépanocytose.
Méd. Trop., 25: 76-84, 1965.
Ohene-Frempong K.
Indications for red cells transfusion in sickle cell disease.
Semin. Hematol., 38: 5-13, 2001.
Okpala I., Daniel Y., Haynes R., Odoemene D., Goldman J.
Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells.
Eur. J. Heamatol., 69:135-144, 2002.
Omanga U., Muganag N, Kapepela M.
Septicémies bactériennes de l’enfant drépanocytaire homozygote. Analyse de soixante-neuf observations.
Ann. Pediatr., 36: 315-318, 1989.
Ono K., Sugioka Y.
Epidemiology and risk factors in avascular osteonecrosis of the femoral head.
In: "Bone circulation and vascularization in normal and pathological conditions".
A. Schoutens, J. Arlet, J.W.M. Gardeniers, Eds; Plenum Press, New York, 1993.
Onwubalili J.K.
Sickle-cell anaemia: an explanation for the ancient myth of reincarnation in Nigeria.
Lancet, 322: 503-505, 1983.
Organisation Mondiale de la Santé (OMS) Soins de santé primaire.
Rapport de la conférence internationale sur les soins primaires, Alma-Ata, 12.09.1978.
Organisation mondiale de la Santé (OMS)
Drépanocytose et autres hémoglobinopathies (août 2006).
http://www.who.int/mediacentre/factsheets/fs308/fr/index.html (consulté le 05.12.2009)
Organisation des Nations Unies (ONU)
Recognition of sickle-cell anaemia as a public health priority.
Résolution 2/7A (III), 18 décembre 2008.
Oufroukhi Y., Biyi A., Zekri A., Doudouh A.
Aspects des complications ostéoarticulaires de la drépanocytose en scintigraphie osseuse planaire (infection exclue).
A propos de trois observations.
Médecine Nucléaire, 32: 361-366, 2008.
Ould Amar A.K., Delattre O., Godbille C., Béra O., Halbout P.A., Catonné Y.
Analyse des pratiques transfusionnelles et complications chez le patient drépanocytaire en situation de chirurgie orthopédique: étude rétrospective.
Trans. Clin. Biol., 10: 61-66, 2003.
Palek, J.
Red cell membrane injury in sickle cell anaemia.
Br. J. Haematol., 35: 1-9, 1977.
Pauling L., Itano H.A., Singer S.J., Wells I.C.
Sickle cell anemia, a molecular disease.
Science, 110: 543-548, 1949.
Pauling L.
Abnormality of hemoglobin molecules in hereditary hemolytic anemias, Harvey Lectures. New York: Academic Press, 216-241, 1955.
Pauling L.
Molecular structure and disease. .
Lowell Lecture, Massachusetts General Hospital, Boston, Massachusetts, pp. 10, October 9, 1958.
Pauling L.
Molecular structure and disease.
In: "Disease and the Advancement of Basic Science", H.K. Beecher, Ed., Cambridge, Mass., Harvard University Press, 1-7, 1960.
Paycha F., Richard B.
Exploration scintigraphique du squelette.
Encycl. Méd. Chir., Radiodiagnostic, Squelette Normal, 30-480-A-10, 1-37, 2001.
Pearson H.A.
Sickle-cell anemia and severe infections due to encapsulated bacteria.
J. Infect. Dis., 136: 25-30, 1977.
Pegelow C.H., Colangelo L., Steinberg M., Wright E.C., Smith J., Phillip G., Vichinsky E.
Natural history of blood pressure in sickle cell diseases: risks for stroke and death associated with relative hypertension in sickle cell anemia.
Am. J. Med., 102: 171-177, 1997.
Pembrey M.E., Wood W.G., Weatherall D.J., Perrine R.P.
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.
Br. J. Haematol., 49: 415-429, 1978.
Perutz M.F., Liquori A.M., Eirich F.
X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients.
Nature, 167: 929-931, 1951.
Platt O.S.
The sickle syndromes.
In: "Blood. Principles and practice of haematology", R.I. Handin, S.E. Lux, T.P. Stossel , Eds., Lippincott Pub., Philadelphia, PA, 1655-1708, 1995.
Poillon W.N., Kim B.C.
2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.
Blood, 76: 1028-1036, 1990.
Poiseuille J.L.M.
Recherches expérimentales sur le mouvement des liquides dans les tubes de très petits diamètres.
Comptes rendus hebdomadaires des séances de l'Académie des sciences, 11: 1041-1048, 1841.
Portnoy B.A., Hérion J.C.
Neurological manifestations in sickle cell disease.
Ann. Int. Med., 76: 343-352, 1972.
Pous J.G., Dimeglio A.
La hanche en croissance.
Encycl. Méd. Chir. Appareil Locomoteur, Paris, 14320 A10, 10-1988.
Powars D.R.
The natural history of sickle-cell disease. The first ten years.
Semin. Hématol., 12: 267-285, 1975.
Pululu E.D.K.
Variations physiopathologiques de la leucocytose dans la morbi-mortalité chez l’enfant drépanocytaire.
Mémoire de fin de spécialisation, Faculté de Médecine, Université de Kinshasa, RDC, pp. 81, 2006.
http://www.memoireonline.com/12/07/845/m_variations-physiopathologiques-leucocytose-morbi-mortalite-enfant- drepanocytaire14.html (consulté le 09.07.2009).
Rachmilewitz, E., Schrier, S.L.
Pathophysiology of β thalassemia.
In: Disorders of hemoglobin: genetics, pathophysiology and clinical management.
M.H. Steinberg, B.G. Forget, D.R. Higgs, R.L. Nagel, eds., Cambridge University Press Pub., New York, pp. 233-251, 2001
Rahimy M.C., Gangbo A., Ahouignan G., Adjou R., Deguenon C., Goussanou S., Alihonou E.
Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting.
Blood, 102: 834-838, 2003.
Ranney, H.M.
Observations on the inheritance of sickle-cell hemoglobin and hemoglobin C.
J. Clin. Invest., 33: 1634-164, 1954.
Rao V.M., Fishman M., Mitchell D.G., Ballas S.K., Axel L., Dalinka M.K., Gefter W., Kressel H.Y.
Painful sickle cells crisis: bone marrow patterns observed with MR imaging.
Radiology, 161: 211-215, 1986.
Rao V.M., Mitchel D.G., Steiner R.M., Rikin M.D.
Femoral head avascular necrosis in sickle cell anemia: MR characteristics.
Magn. Reson. Imaging, 6: 661-667, 1988.
Ratcliff R.G., Wolf M.C.
Avascular necrosis of the femoral head associated with sickle- cell trait (AS hemoglobin).
Ann. Intern. Med., 57: 299-304, 1962.
